7erc - Revision history

OCA at 17:00, 29 November 2023

2023-11-29T17:00:46Z

← Older revision		Revision as of 17:00, 29 November 2023
Line 3:		Line 3:
	<StructureSection load='7erc' size='340' side='right'caption='[[7erc]], [[Resolution\|resolution]] 1.50Å' scene=''>		<StructureSection load='7erc' size='340' side='right'caption='[[7erc]], [[Resolution\|resolution]] 1.50Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[7erc]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7ERC OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7ERC FirstGlance]. <br>		<table><tr><td colspan='2'>[[7erc]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7ERC OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7ERC FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=JBL:4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic+acid'>JBL</scene>, <scene name='pdbligand=NAP:NADP+NICOTINAMIDE-ADENINE-DINUCLEOTIDE+PHOSPHATE'>NAP</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>		</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.5Å</td></tr>
			<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=JBL:4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic+acid'>JBL</scene>, <scene name='pdbligand=NAP:NADP+NICOTINAMIDE-ADENINE-DINUCLEOTIDE+PHOSPHATE'>NAP</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7erc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7erc OCA], [https://pdbe.org/7erc PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7erc RCSB], [https://www.ebi.ac.uk/pdbsum/7erc PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7erc ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7erc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7erc OCA], [https://pdbe.org/7erc PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7erc RCSB], [https://www.ebi.ac.uk/pdbsum/7erc PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7erc ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
	[[https://www.uniprot.org/uniprot/BLVRB_HUMAN BLVRB_HUMAN]] Broad specificity oxidoreductase that catalyzes the NADPH-dependent reduction of a variety of flavins, such as riboflavin, FAD or FMN, biliverdins, methemoglobin and PQQ (pyrroloquinoline quinone). Contributes to heme catabolism and metabolizes linear tetrapyrroles. Can also reduce the complexed Fe(3+) iron to Fe(2+) in the presence of FMN and NADPH. In the liver, converts biliverdin to bilirubin.<ref>PMID:10620517</ref>		[https://www.uniprot.org/uniprot/BLVRB_HUMAN BLVRB_HUMAN] Broad specificity oxidoreductase that catalyzes the NADPH-dependent reduction of a variety of flavins, such as riboflavin, FAD or FMN, biliverdins, methemoglobin and PQQ (pyrroloquinoline quinone). Contributes to heme catabolism and metabolizes linear tetrapyrroles. Can also reduce the complexed Fe(3+) iron to Fe(2+) in the presence of FMN and NADPH. In the liver, converts biliverdin to bilirubin.<ref>PMID:10620517</ref>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 18:		Line 19:
	</div>		</div>
	<div class="pdbe-citations 7erc" style="background-color:#fffaf0;"></div>		<div class="pdbe-citations 7erc" style="background-color:#fffaf0;"></div>

			==See Also==
			*[[Flavin reductase\|Flavin reductase]]
	== References ==		== References ==
	<references/>		<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
			[[Category: Homo sapiens]]
	[[Category: Large Structures]]		[[Category: Large Structures]]
	[[Category: Griesinger, C]]		[[Category: Griesinger C]]
	[[Category: Ha~~, J H~~]]		[[Category: Ha JH]]
	[[Category: Kim, M]]		[[Category: Kim M]]
	[[Category: Lee, D]]		[[Category: Lee D]]
	[[Category: Ryu~~, K S]]~~		[[Category: Ryu KS]]
	~~[[Category: Biliverdin reductase b]]~~
	~~[[Category: Blvrb]]~~
	~~[[Category: Deferasirox]]~~
	~~[[Category: Inhibitor]]~~
	~~[[Category: Nadp]]~~
	~~[[Category: Oxidoreductase]]~~
	~~[[Category: Platelet~~]]

OCA at 08:37, 23 February 2022

2022-02-23T08:37:22Z

← Older revision		Revision as of 08:37, 23 February 2022
Line 1:		Line 1:

	==Crystal structure of human Biliverdin IX-beta reductase B with Deferasirox (ICL)==		==Crystal structure of human Biliverdin IX-beta reductase B with Deferasirox (ICL)==
	<StructureSection load='7erc' size='340' side='right'caption='[[7erc]]' scene=''>		<StructureSection load='7erc' size='340' side='right'caption='[[7erc]], [[Resolution\|resolution]] 1.50Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7ERC OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7ERC FirstGlance]. <br>		<table><tr><td colspan='2'>[[7erc]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7ERC OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7ERC FirstGlance]. <br>
	</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7erc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7erc OCA], [https://pdbe.org/7erc PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7erc RCSB], [https://www.ebi.ac.uk/pdbsum/7erc PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7erc ProSAT]</span></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=JBL:4-[3,5-bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic+acid'>JBL</scene>, <scene name='pdbligand=NAP:NADP+NICOTINAMIDE-ADENINE-DINUCLEOTIDE+PHOSPHATE'>NAP</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
			<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7erc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7erc OCA], [https://pdbe.org/7erc PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7erc RCSB], [https://www.ebi.ac.uk/pdbsum/7erc PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7erc ProSAT]</span></td></tr>
	</table>		</table>
			== Function ==
			[[https://www.uniprot.org/uniprot/BLVRB_HUMAN BLVRB_HUMAN]] Broad specificity oxidoreductase that catalyzes the NADPH-dependent reduction of a variety of flavins, such as riboflavin, FAD or FMN, biliverdins, methemoglobin and PQQ (pyrroloquinoline quinone). Contributes to heme catabolism and metabolizes linear tetrapyrroles. Can also reduce the complexed Fe(3+) iron to Fe(2+) in the presence of FMN and NADPH. In the liver, converts biliverdin to bilirubin.<ref>PMID:10620517</ref>
			<div style="background-color:#fffaf0;">
			== Publication Abstract from PubMed ==
			Biliverdin IXbeta reductase B (BLVRB) has recently been proposed as a novel therapeutic target for thrombocytopenia through its reactive oxygen species (ROS)-associated mechanism. Thus, we aim at repurposing drugs as new inhibitors of BLVRB. Based on IC50 (<5 muM), we have identified 20 compounds out of 1496 compounds from the Food and Drug Administration (FDA)-approved library and have clearly mapped their binding sites to the active site. Furthermore, we show the detailed BLVRB-binding modes and thermodynamic properties (DeltaH, DeltaS, and KD) with nuclear magnetic resonance (NMR) and isothermal titration calorimetry together with complex structures of eight water-soluble compounds. We anticipate that the results will serve as a novel platform for further in-depth studies on BLVRB effects for related functions such as ROS accumulation and megakaryocyte differentiation, and ultimately treatments of platelet disorders.

			Repositioning Food and Drug Administration-Approved Drugs for Inhibiting Biliverdin IXbeta Reductase B as a Novel Thrombocytopenia Therapeutic Target.,Kim M, Ha JH, Choi J, Kim BR, Gapsys V, Lee KO, Jee JG, Chakrabarti KS, de Groot BL, Griesinger C, Ryu KS, Lee D J Med Chem. 2021 Dec 27. doi: 10.1021/acs.jmedchem.1c01664. PMID:34957824<ref>PMID:34957824</ref>

			From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
			</div>
			<div class="pdbe-citations 7erc" style="background-color:#fffaf0;"></div>
			== References ==
			<references/>
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
	[[Category: Large Structures]]		[[Category: Large Structures]]
	[[Category: Griesinger C]]		[[Category: Griesinger, C]]
	[[Category: Ha JH]]		[[Category: Ha, J H]]
	[[Category: Kim M]]		[[Category: Kim, M]]
	[[Category: Lee D]]		[[Category: Lee, D]]
	[[Category: Ryu KS]]		[[Category: Ryu, K S]]
			[[Category: Biliverdin reductase b]]
			[[Category: Blvrb]]
			[[Category: Deferasirox]]
			[[Category: Inhibitor]]
			[[Category: Nadp]]
			[[Category: Oxidoreductase]]
			[[Category: Platelet]]

OCA at 07:27, 19 January 2022

2022-01-19T07:27:35Z

← Older revision		Revision as of 07:27, 19 January 2022
Line 1:		Line 1:
	~~'''Unreleased structure'''~~

	~~The entry~~ 7erc is ~~ON HOLD until Paper Publication~~		==Crystal structure of human Biliverdin IX-beta reductase B with Deferasirox (ICL)==
			<StructureSection load='7erc' size='340' side='right'caption='[[7erc]]' scene=''>
	~~Authors~~:		== Structural highlights ==
			<table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7ERC OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7ERC FirstGlance]. <br>
	~~Description~~:		</td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7erc FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7erc OCA], [https://pdbe.org/7erc PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7erc RCSB], [https://www.ebi.ac.uk/pdbsum/7erc PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7erc ProSAT]</span></td></tr>
	[[Category: ~~Unreleased Structures~~]]		</table>
			__TOC__
			</StructureSection>
			[[Category: Large Structures]]
			[[Category: Griesinger C]]
			[[Category: Ha JH]]
			[[Category: Kim M]]
			[[Category: Lee D]]
			[[Category: Ryu KS]]

OCA at 13:30, 17 June 2021

2021-06-17T13:30:03Z

← Older revision		Revision as of 13:30, 17 June 2021
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

	The entry 7erc is ON HOLD		The entry 7erc is ON HOLD until Paper Publication

	Authors:		Authors:

OCA: Protected "7erc" [edit=sysop:move=sysop]

2021-05-12T08:05:51Z

Protected "7erc" [edit=sysop:move=sysop]

← Older revision	Revision as of 08:05, 12 May 2021
(No difference)

OCA: New page: '''Unreleased structure''' The entry 7erc is ON HOLD Authors: Description: Category: Unreleased Structures

2021-05-12T08:05:50Z

New page: '''Unreleased structure''' The entry 7erc is ON HOLD Authors: Description: Category: Unreleased Structures

New page

'''Unreleased structure'''

The entry 7erc is ON HOLD

Authors:

Description:
[[Category: Unreleased Structures]]